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General. All reactions were carried out under Ar in pre-dried glassware using Schlenk
techniques. The solvents were dried by distillation over the drying agents indicated
and were stored and transferred under Ar: CH2Cl2 (P4O10), toluene (Na/K), Et2O,
THF (magnesium/anthracene), EtOH (Mg). Flash chromatography: Merck silica gel
(230-400 mesh). Mp: Gallenkamp apparatus (uncorrected). NMR: Spectra were
recorded on a Bruker DPX 300 spectrometer in the solvent indicated. Chemical shifts
(δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The multiplicity in
the 13C NMR spectra refers to the geminal protons (DEPT). IR: Nicolet FT-7199,
wavenumbers in cm-1. MS: Finnigan MAT 8200 (70 eV); HRMS: Finnigan MAT SSQ
7000 (70 eV). Elemental analyses: Dornis & Kolbe, Mülheim. Commercially available
reagents (Aldrich, Fluka) were used as received.
2-(Bromomethyl)acrylic acid (S)-1-methylallylester (S-6). A solution of PPh3 (1.78
g, 6.6 mmol) and (R)-1-buten-3-ol (R)-4 (0.86 mL, 10 mmol, er ≥ 97:3) in Et2O (10
mL) was slowly added to a solution of diethyl azodicarboxylate (DEAD, 0.95 mL, 6.6
mmol) and 2-(bromomethyl)acrylic acid 5 (1 10 g 6 6 mmol) in Et2O (10 mL) at 0 °C
After stirring for 16 hours at ambient temperature, the precipitated solids were filtered
off through a pad of silica and the filtrate was evaporated. Flash chromatography
(hexane/EtOAc, 10:1) of the crude product afforded ester (S)-6 as a colorless liquid
(1.00 g, 71%); [α]D20 = + 5.5° (c = 0.5; CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.32
(s, 1H), 5.93 (s, 1H), 5.85 (ddd, 1H, J = 16.8, 10.0, 6.5 Hz), 5.45 (quin, 1H, J = 6,5
Hz), 5.27 (d, 1H, J = 16.8 Hz), 5.15 (d, 1H, J = 10.0 Hz), 4.17 (s, 1H), 1.36 (d, 3H, J =
6.5 Hz); 13C NMR (75 MHz, CDCl3): δ 163.9 (C), 137.7 (C), 137.2 (CH), 128.9
(CH2), 116.0 (CH2), 72.0 (CH), 29.3 (CH2), 19.8 (CH3); IR (neat): 3089, 2983, 1724,
1632, 1350, 1307, 1223, 1187, 990, 931 cm-1; MS (EI) m/z (rel. intensity): 220 ([M+],
< 1), 149 (72), 147 (74), 139 (23), 121 (17), 119 (18), 111 (11), 93 (28), 71 (11), 55
(100), 54 (27), 53 (12), 42 (14), 40 (26), 39 (61), 29 (22), 27 (24); C8H11O2Br
(218.90) calcd: C, 43.86; H, 5.06; found: C, 43.70; H, 5.20.
2-Methylene-undec-9-ynoic acid (S)-1-methylallylester (9). A stirred suspension of
zinc dust (1.63 g, 25.0 mmol) and 1,2-dibromoethane (107 µL, 5 mol%) in THF (25
mL) was heated to 60 °C for 1 min. The mixture was allowed to cool to ambient
temperature prior to addition of TMSCl (77 µl, 3 mol%) and stirring for another 15
min. A solution of 1,5-diiodopentane 7 (930 µL, 6.3 mmol) in THF (5 mL) was then
slowly introduced to the suspension of the activated zinc and the mixture was stirred at
40°C for 24 h. Remaining solids were allowed to settle at room temperature and the
supernatant liquid was transferred via cannula into a cooled (–60°C) solution of CuCN
(0.535 g, 6.2 mmol) and LiCl (0.529 g, 12.5 mmol) in THF (20 mL). The resulting
yellow-green mixture turned blue while stirring for another 15 min at 0°C. The
reaction mixture was again cooled to –78 °C and 1-iodo-1-propyne (0.35 g, 2.1 mmol)
dissolved in THF (3 mL) was introduced. After stirring for 15 h at – 35 °C, a solution
of ester (S)-6 (2.00 g, 9.4 mmol) in THF (3 mL) was added at – 78°C and the mixture
was kept for 1h at ambient temperature. For work-up, the resulting blue suspension
was diluted with ether (100 mL) and washed with sat. aq. NH4Cl (100 mL). The
aqueous phase was extracted with ether (3 x 50 mL) the combined organic layers were
dried (Na2SO4), filtered and evaporated. Flash chromatography (hexane/EtOAc, 50:1)
of the crude material afforded compound 9 as a colorless liquid (754 mg, 70%). [α]D20
= + 14.2° (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.11 (d, 1H, J = 1.4 Hz),
5.85 (ddd, 1H, J = 17.1, 10.5, 5.8 Hz), 5.48 (t, 1H, J = 1.4 Hz), 5.38 (tquin., 1H, J =
5.8, 1.4 Hz), 5.23 (dt, 1H, J = 17.1, 1.4 Hz), 5.11 (dt, 1H, J = 10.5, 1.4 Hz), 2.27 (t,
2H, J = 7.0 Hz), 2.09 (tq, 2H, J = 6.8, 2.5 Hz), 1.75 (t, 3H, J = 2.5 Hz), 1.58 – 1,34 (m,
8H), 1.32 (d, 3H, J = 6.8 Hz); 13C NMR (75 MHz, CDCl3): δ 166.5 (C), 141.2 (C),
137.7 (CH), 124.3 (CH2), 115.6 (CH2), 79.3 (C), 75.4 (C), 71.1 (CH), 31.8 (CH2),
28.9 (CH2), 28.7 (CH2), 28.6 (CH2), 28.3 (CH2), 19.9 (CH3), 18.7 (CH2), 3.4 (CH3);
IR (neat): 3089, 2980, 2932, 1717, 1631, 1449, 1373, 1274, 1170, 1140, 1048, 990,
937 cm-1; MS (EI) m/z (rel. intensity): 248 ([M+], < 1), 147 (14), 121 (18), 109 (13),
108 (14), 107 (31), 105 (16), 95 (21), 93 (42), 91 (18), 81 (32), 79 (31), 69 (14), 68
(24), 67 (35), 55 (100), 53 (26), 43 (14), 41 (31), 39 (19), 29 (19), 27 (14). HR-MS
calcd: 248.17763; found: 248.17780.
5-(S)-(Methyl)-3-(non-7-ynyl)-(5H)-furan-2-one (11). Solutions of substrate 9 (450
mg, 1.89 mmol) and the ruthenium complex (PCy3)2Cl2Ru=CHPh 10 (265 mg, 16
mol%) in CH2Cl2 (50 mL each) were added over a period of ca. 8 h via two dropping
funnels to refluxing CH2Cl2 (900 mL). After 24 hours reaction time, the solvent was
evaporated and the residue was purified by flash chromatography (pentane/Et2O, 10:1)
affording product 11 as a pale yellow liquid (291 mg, 70 %). [α]D20 = + 18.5° (c = 1.0,
CHCl3); 1H NMR (300 MHz, CDCl3): δ 6.95 (q, 1H, J = 1.5 Hz), 4.95 (qq, 1H, J =
6.7, 1.7 Hz), 2.22 (t, 2H, J = 7.5 Hz), 2.08 (qt, 2H, J = 6.7, 2.5 Hz), 1.72 (t, 3H, J = 2.5
Hz), 1.54 – 1.20 (m, 11H); 13C NMR (75 MHz, CDCl3): δ 173.8 (C), 149.0 (CH),
134.1 (C), 79.1 (C), 77.4 (CH), 75.4 (C), 28.8 (CH2), 28.6 (CH2), 28.4 (CH2), 27.2
(CH2), 25.0 (CH2), 19.1 (CH3), 18.6 (CH2), 3.4 (CH3); IR (neat): 3078, 2979, 2932,
1755, 1653, 1449, 1319, 1119, 1101, 1084, 1066, 1026 cm-1; MS (EI) m/z (rel.
intensity): 220 ([M+], 3), 191 (15), 175 (19), 165 (11), 153 (44), 147 (14), 133 (18),
121 (15) 119 (24) 112 (41) 111 (16) 109 (55) 108 (30) 107 (39) 105 (26) 95 (35)
94 (16), 91 (33), 81 (46), 80 (18), 79 (75), 77 (25), 68 (62), 67 (100), 66 (17), 65 (17),
55 (52), 54 (20), 53 (55), 43 (71), 41 (76), 39 (45), 29 (22), 27 (35). HR-MS calcd:
220.14633; found: 220.14626.
1,14-Bis-[5-(S)-methyl-(5H)-furan-2-on-3-yl]-tetradec-7-yne (13). A solution of
(tBuO)3W≡CCMe3 12 (46 mg, 10 mol%) in toluene (10 mL) was added to a solution
of compound 11 (204 mg, 0.977 mmol) in toluene (80 mL). The resulting mixture was
heated at 100 °C for 21 h. The solvent was removed in vacuo and the residue was
purified by flash chromatography (hexane/EtOAc, 4:1) delivering product 13 as a
colorless syrup (146 mg, 75 %). [α]D20 = + 37.5° (c = 1.0, CHCl3); 1H NMR (300
MHz, CDCl3): δ 6.97 (q, 2H, J = 1.7 Hz), 4.97 (qq, 2H, J = 6.8, 1.7 Hz), 2.24 (tt, 4H, J
= 7.3, 1.5 Hz), 2.11 (t, 4H, J = 6.8 Hz), 1.60 – 1.31 (m, 22H); 13C NMR (75 MHz,
CDCl3): δ 173.8 (C), 149.0 (CH), 134.1 (C), 80.1 (C), 77.4 (CH), 28.9 (CH2), 28.7
(CH2), 28.4 (CH2), 27.3 (CH2), 25.1 (CH2), 19.2 (CH3), 18.7 (CH2); IR (neat): 3081,
2980, 2932, 1753, 1653, 1454, 1373, 1319, 1101, 1084, 1026 cm-1; MS (EI) m/z (rel.
intensity): 386 ([M+], 29), 368 (35), 340 (11), 275 (16), 234 (13), 220 (27), 205 (12),
201 (21), 191 (19), 187 (26), 177 (20), 175 (21), 173 (27), 167 (29), 161 (20), 159
(26), 153 (23), 147 (32), 145 (24), 139 (16), 135 (21), 133 (34), 123 (24), 121 (39),
119 (32), 112 (32), 111 (20), 109 (42), 108 (24), 107 (49), 105 (35), 95 (65), 94 (25),
93 (68), 91 (48), 81 (78), 90 (24), 79 (83), 77 (28), 67 (100), 55 (60), 53 (25), 43 (82),
41 (61); HR-MS calcd: 386.24570; found: 386.24543.
 (1,14-Bis-[5-(S)-methyl-(5H)-furan-2-on-3-yl]-tetradec-7-ene (3). Quinoline (95 µL
of a stock solution [40 µL quinoline in 20 mL hexane]) and alkyne 13 (25 mg, 0.064
mmol) were dissolved in hexane/EtOH (5 mL, 1:1). Commercially available Lindlar
catalyst (13 mg, 10 mol%) was added and the resulting suspension was stirred for 10
min under an atmosphere of H2 (1 atm). The catalyst was filtered off through a pad of
Celite, the solvent was evaporated and the residue was purified by flash
chromatography (hexane/EtOAc 2:1) to afford dehydrohomoancepsenolide (3) as a
colorless solid (24 mg, 94%). Mp = 99-100°C; [α]D20 = + 27.2° (c = 1.0; CHCl3)
[ref.7: [α]D25 = + 29.7° (c = 2.1, CHCl3)]; 1H NMR (300 MHz, CD2Cl2): δ 6.96 (q,
2H, J = 1.4 Hz), 5.33 (m, 2H), 4.97 (dq, 2H, J = 6.7, 1.2 Hz), 2.24 (t, 4H, J = 7.8), 1.97
(m, 4H), 1.52 (m, 4H), 1.37 (d, 6H, J = 6.8 Hz), 1.30 (m, 12H); 13C NMR (75 MHz,
CD2Cl2): δ 173.9 (C), 148.9 (CH), 134.3 (C), 129.8 (CH), 77.2 (CH), 29.6 (CH2), 29.1
(CH2), 28.9 (CH2), 27.4 (CH2), 27.1 (CH2), 25.2 (CH2), 19.2 (CH3); IR (KBr): 3076,
2978, 2920, 2851, 1747, 1652, 1463, 1374, 1321, 1120, 1085, 1028, 759 cm-1; MS
(EI) m/z (rel. intensity): 388 ([M+], 100), 370 (56), 345 (13), 342 (14), 277 (10), 195
(10), 189 (27), 175 (41), 161 (31), 149 (22), 147 (25), 139 (17), 137 (16), 136 (22),
135 (32), 133 (22), 123 (25), 122 (22), 121 (35), 112 (30), 109 (37), 107 (32), 95 (56),
93 (43), 81 (70), 79 (44), 69 (38), 67 (95), 55 (79), 43 (91), 41 (67); C24H36O4
(388.22) calcd: C, 74.19; H, 9.34; found: C, 74.28; H, 9.26.
